A method for interfacing applications to maintain data integrity. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. polyethylene terephthalate, polybutylene terephthalate, polynaphthalene terephthalate, polytrimethylene terephthalate andor polyesters of other dicarboxylic acids and diols including copolymers thereof.